Department of Anesthesiology, University of Washington and Center for Developmental Therapeutics, Seattle Children's Research Institute, Seattle, WA 98101-1304, USA.
Anesth Analg. 2011 Jun;112(6):1321-9. doi: 10.1213/ANE.0b013e3182121d37. Epub 2011 Apr 5.
Complex I of the electron transport chain (ETC) is a possible target of volatile anesthetics (VAs). Complex I enzymatic activities are inhibited by VAs, and dysfunction of complex I can lead to hypersensitivity to VAs in worms and in people. Mutant analysis in Caenorhabditis (C.) elegans suggests that VAs may specifically interfere with complex I function at the binding site for its substrate ubiquinone. We hypothesized that isoflurane inhibits electron transport by competing with ubiquinone for binding to complex I.
Wildtype and mutant C. elegans were used to study the effects of isoflurane on isolated mitochondria. Enzymatic activities of the ETC were assayed and dose-response curves determined using established techniques. Two-dimensional native gels of mitochondrial proteins were performed after exposure of mitochondria to isoflurane.
Complex I is the most sensitive component of the ETC to isoflurane inhibition; however, the proximal portion of complex I (the flavoprotein) is relatively insensitive to isoflurane. Isoflurane and quinone do not compete for a common binding site on complex I. The absolute rate of complex I enzymatic activity in vitro does not predict immobilization of the animal by isoflurane. Isoflurane had no measurable effect on stability of mitochondrial supercomplexes. Reduction of ubiquinone by complex I displayed positive cooperative kinetics not disrupted by isoflurane.
Isoflurane directly inhibits complex I at a site distal to the flavoprotein subcomplex. However, we have excluded our original hypothesis that isoflurane and ubiquinone compete for a common hydrophobic binding site on complex I. In addition, immobilization of the nematode by isoflurane is not due to limiting absolute amounts of complex I electron transport as measured in isolated mitochondria.
电子传递链复合物 I(ETC)是挥发性麻醉剂(VAs)的可能作用靶点。VA 会抑制复合物 I 的酶活性,而复合物 I 功能障碍可导致蠕虫和人类对 VA 产生超敏反应。秀丽隐杆线虫(C. elegans)的突变分析表明,VA 可能特异性地通过与复合物 I 的底物泛醌结合位点竞争来干扰复合物 I 的功能。我们假设异氟醚通过与泛醌竞争结合复合物 I 来抑制电子传递。
使用野生型和突变型秀丽隐杆线虫研究异氟醚对分离线粒体的影响。使用既定技术测定 ETC 的酶活性并确定剂量反应曲线。用异氟醚处理线粒体后,进行线粒体蛋白二维天然凝胶电泳。
复合物 I 是 ETC 对异氟醚抑制最敏感的成分;然而,复合物 I 的近端部分(黄素蛋白)对异氟醚相对不敏感。异氟醚和醌不竞争复合物 I 上的共同结合位点。体外复合物 I 酶活性的绝对速率并不能预测动物被异氟醚固定。异氟醚对线粒体超级复合物的稳定性没有可测量的影响。复合物 I 还原泛醌显示出正协同动力学,不受异氟醚的破坏。
异氟醚直接在远离黄素蛋白亚复合物的部位抑制复合物 I。然而,我们排除了我们最初的假设,即异氟醚和泛醌竞争复合物 I 上的共同疏水性结合位点。此外,异氟醚固定线虫不是由于在分离的线粒体中测量的复合物 I 电子传递的绝对量有限。